The publication of the fifth version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) in 2013 raises important questions for clinical trials and associated regulatory decisions on new drugs for psychiatric disorders. © 2012 Macmillan Publishers Limited. All rights reserved.
DSM-5 and clinical trials in psychiatry: Challenges to come? / Butlen-Ducuing, F.; Haas, M.; Pani, L.; Van Zwieten-Boot, B.; Broich, K.. - In: NATURE REVIEWS DRUG DISCOVERY. - ISSN 1474-1776. - 11:8(2012), pp. 583-584. [10.1038/nrd3811]
DSM-5 and clinical trials in psychiatry: Challenges to come?
Pani L.;
2012
Abstract
The publication of the fifth version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) in 2013 raises important questions for clinical trials and associated regulatory decisions on new drugs for psychiatric disorders. © 2012 Macmillan Publishers Limited. All rights reserved.Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris